Navigation Links
LSUHSC research discovers new targets for treatment of invasive breast cancer
Date:8/19/2009

n estimated 40,610 breast cancer deaths (40,170 women, 440 men) are expected in 2009. Breast cancer ranks second as a cause of cancer death in women (after lung cancer).

"We are in the process of confirming these results and these studies will reveal whether ST14 can reduce breast tumor growth in animals," notes Dr. Alahari, who is also a member of the LSUHSC Stanley S. Scott Cancer Center. "Blocking the miR-27b/ST14 interaction or rescuing ST14 function may be an effective therapeutic approach to advance breast cancer treatment."


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. LSUHSC contributes to revealing targets to reduce racial disparity in prostate cancer deaths
2. LSUHSC research identifies enzyme that makes survival molecule for key vision cells
3. LSUHSC research finds single gene controls growth of some cancers
4. LSUHSC researchers first to document early signs for diabetes in kids as young as 7
5. LSUHSC dental researcher funded to develop better dental materials
6. LSUHSC research shows fish oil protects against diseases like Parkinsons
7. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
8. LSUHSCs England leads development of new testing guidelines for common nerve disorder
9. LSUHSCs Dr. Xiao Cheng Wu co-authors annual report to the nation on cancer
10. LSUHSCs Fontham makes history
11. LSUHSC public health contributes to estimate of HPV-related cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2010)... -- TeamHealth Holdings, Inc. ("TeamHealth") (NYSE: TMH ... professional staffing and administrative services to hospitals and other ... announced that its management will be presenting at the ... 24, 2010 , at the Loews Miami Hotel, ... AM Eastern time .  Interested investors and other parties ...
(Date:3/16/2010)... 2010)One of the most dangerous characteristics of cancer is ... For this reason, oncologists have a major need for ... primary tumors to travel to other parts of the ... as circulating tumor cells (CTC,s), could help guide treatment ... A commentary in the March 17 issue of the ...
(Date:3/16/2010)... to a recent online survey by Jackson Healthcare, 89 percent ... compensation. , ... Alpharetta, GA (Vocus) ... by Jackson Healthcare , 89 percent of physicians agree ... , , ,Negligence, they said, should be determined by a ...
(Date:3/16/2010)... surgery died soon after than those using Brilinta, ... In a trial comparing two anti-clotting drugs, patients given ... die than those given Plavix, researchers found. , Both ... Plavix, the more popular drug, has been linked to ... some people don,t metabolize it well, making it less ...
(Date:3/16/2010)... , March 16 The following is a statement from Charles Lyons , President and CEO of the Elizabeth Glaser Pediatric ... ... ... ... ...
Breaking Medicine News(10 mins):Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 2Health News:TeamHealth Holdings, Inc., to Present at Barclays Capital Global Healthcare Conference 3Health News:Revisiting the need to detect circulating tumor cells 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 2Health News:Recent Survey Reveals That Physicians Overwhelmingly Support Patient Compensation When Harmed 3Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 2Health News:Newer Blood Thinner Beats Plavix for Bypass Patients 3Health News:Elizabeth Glaser Pediatric AIDS Foundation President and CEO Charles Lyons Welcomes the Appointment of Anthony Lake as New Executive Director of UNICEF 2
... condition where the salt and water balance in the ... usually is triggered off by other conditions and requires ... Medicine (NLM) says that some of the symptoms caused ... fatigue, and headache. Other serious signs are convulsions, hallucinations, ...
... to be published in the August 27 Advance Online issue ... ovarian development have been unraveled by// scientists at NYU School ... are not well understood. They are essential as they ... it is injured, ascertain if it is growing and developing ...
... phase of clinical trials of a bird flu vaccine for ... and effective.// ,The vaccine developed jointly by China's ... company, Beijing Sinovac Biotech Co., was tested on six human ... the vaccine developers were given the green light by the ...
... coroner Jacques Ramsay has recommended that Canadians suffering from ... or the Twinject, which// provides a double dose in ... situations. He has also called for manufacturers ... the patients. ,The recommendations follow the investigation ...
... holding back the HIV tests of dental patients in ... after Dr Young, a dentist working// at Bowen and ... off large scale testing of patients. Nearly 120 patients ... ,Queensland Health's Dr Jeannette Young expressed that despite some ...
... study by British Heart Foundation (BHF) suggested that people with ... older than their real age.// ... they examined tissues from heart bypass and transplant patients to ... found that the artery cells divide seven to 13 times ...
Other Medicine News:Health News:Feedback Loop Governing Ovarian Development Unraveled 2Health News:Feedback Loop Governing Ovarian Development Unraveled 3Health News:Feedback Loop Governing Ovarian Development Unraveled 4
(Date:3/16/2010)... March 16 Watson Pharmaceuticals, Inc. (NYSE: WPI ), ... and chief executive officer, will provide an overview and update of the Company,s business ... at 11:15 am Eastern Daylight Savings Time at the Loews Miami Beach ... ... ...
(Date:3/16/2010)... March 16 Medicare has been touting the merits ... services (HME) to convince Congress that the program is good for seniors. Unfortunately, ... and ignore the severe shortcomings of the program. , ... ... ...
(Date:3/16/2010)... Connecticut , March 16, 2010 ... Call Systems and Visonic Technologies a global,provider ... and management,solutions for the healthcare industry announce ... Responder 5 Nurse Call System. This joint ... 5 with,real-time staff presence functionality throughout the ...
Breaking Medicine Technology:Watson to Present at Barclay's 2010 Global Healthcare Conference 2Watson to Present at Barclay's 2010 Global Healthcare Conference 3Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 2Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 3Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 4Discussion of Medicare's 'Competitive' Bidding Program for Home Medical Equipment is Plagued by Myths and Misinformation 5Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 2Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 3Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System 4Cardiome Announces Investigational Candidate Vernakalant Meets Primary Endpoint in European Comparator Study 63532 1Cardiome Announces Investigational Candidate Vernakalant Meets Primary Endpoint in European Comparator Study 63532 2Cardiome Announces Investigational Candidate Vernakalant Meets Primary Endpoint in European Comparator Study 63532 3Cardiome Announces Investigational Candidate Vernakalant Meets Primary Endpoint in European Comparator Study 63532 4 2424 Million Settlement of New York State and Federal False Claims Act Case 63528 1 2424 Million Settlement of New York State and Federal False Claims Act Case 63528 2ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once Daily XiDay 28TM 29 7111 1ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once Daily XiDay 28TM 29 7111 2ISTA Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Once Daily XiDay 28TM 29 7111 3
... Mass., Aug. 14 StatSure,Diagnostic Systems, Inc. (OTC Bulletin ... patented, "barrel- test" format for the detection of,antibodies to ... completed,the trials needed for a CLIA waiver application and ... Food & Drug Administration (FDA) for,their review. The Company ...
... 15 CV Therapeutics,Inc. (Nasdaq: CVTX ) ... American College of Cardiology Foundation and the American ... Circulation, state that,"ranolazine may be safely administered for ... tablets) is indicated for the,treatment of chronic angina ...
Other Medicine Technology:CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology 2CLIA Waiver Submitted for Rapid HIV Test Employs StatSure's 'Barrel' Technology 3Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2
Clip-On Glasses clip onto regular eyewear frames. Plano (nonprescription) only. Will not fit over high-plus or high-minus presciptions, or over glasses with thick frames. Black wire frames. Wt. 63 g....
The Bronze Metalite Constructed of optical-grade steel with bronze electroplate. Fitted lead side shields that create a seal to the front of the lenses for increased scatter protection....
Provide 1.5mm protection throughout. Six durable, attractive vinyl coverings are available. Lead glass window factory installed. Larger window available....
RayShield Frame Mounted Overhead Lead Acrylic Barriers are offered in a choice of three sizes: 60 cm x 80 cm ( 24" x 32") wide, 60 cm x 50 cm( 24" x 20") wide. Lead acrylic windows of 0.5 mm and 1.0 ...
Medicine Products: